Physician profile

Gary S Allen

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tavares, FL

NPI 1154327872

$53,011.70

in general payments reported to CMS, 2019-2025

32 companies · $38K in 2025

The $38K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$34,500.00
Food and Beverage$6,878.86
Travel and Lodging$6,564.39
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$1,300.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $42,357.49 2024-2025
Edwards Lifesciences Corporation $1,803.12 2020-2025 Mitris Resilia Mitral Valve, Hemosphere
Artivion, INC. $1,784.44 2019-2024 On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft, Bioglue Surgical Adhesive
Zimmer Biomet Holdings, INC. $1,178.28 2021-2023 Sternalock Blu System
Abbott Laboratories $1,159.05 2021-2023 Thoratec Heartmate 3 Lvas Implant Kit
Abiomed $1,034.09 2022-2025 Impella
Getinge USA Sales, LLC $927.05 2020-2025 Cardiohelp, Sensation 7fr. 34cc Iab, Cardiohelp
Baxter Healthcare $726.10 2019-2024 Tisseel
Atricure, INC. $332.83 2021-2024
Nxstage Medical, INC. $209.19 2022-2023 Nxstage System One, Novalung System, Nxstage Cartridge Express
Livanova USA, INC. $199.55 2020-2021
Medtronic, INC. $149.26 2022-2023 Concertotm
Nuwellis, INC. $146.91 2019
Corcym INC $127.66 2023 Perceval
Fresenius USA Marketing, INC. $90.09 2021
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Covidien LP $88.67 2019
Pacira Pharmaceuticals Incorporated $87.92 2024-2025 Exparel
Medtronic Vascular, INC. $83.51 2019
Ethicon US, LLC $82.08 2019-2022
W. L. Gore & Associates, INC. $65.70 2023 Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Iliac Branch Endoprosthesis
Boston Scientific Corporation $48.23 2022-2023 Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack
Medline Industries LP $45.86 2025
Globus Medical, INC. $42.77 2025 Harvest
Janssen Pharmaceuticals, INC $36.45 2021
Philips North America LLC $33.57 2023
Hemosonics LLC $32.55 2021
Angiodynamics, INC. $32.12 2024 Alphavac
Davol INC. $29.03 2025 Progel Applicator Spray Tips
Ethicon INC. $22.47 2021
Bard Peripheral Vascular, INC. $19.33 2022
Silk Road Medical, INC. $18.46 2022
Convatec INC. $17.87 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gary S Allen

$53,011.70

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $38K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/233040/gary-s-allen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.